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chronic human diseases, including diabetes, colon cancer, and obesity. This review provides a transdisciplinary
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digestion resistance; methods for starch analysis; challenges in developing food products with resistant
starches; mammalian intestinal and gut bacterial metabolism; potential effects on gut microbiota; and impacts
and mechanisms for the prevention and control of colon cancer, diabetes, and obesity. Although this has been
an active area of research and considerable progress has been made, many questions regarding how to best use
digestion-resistant starches in human diets for disease prevention must be answered before the full potential
of resistant starches can be realized.
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ABSTRACT
Ongoing research to develop digestion-resistant starch for human health promotion integrates the disciplines of starch chemistry, agronomy,
analytical chemistry, food science, nutrition, pathology, and microbiology. The objectives of this research include identifying components of
starch structure that confer digestion resistance, developing novel plants and starches, and modifying foods to incorporate these starches.
Furthermore, recent and ongoing studies address the impact of digestion-resistant starches on the prevention and control of chronic human
diseases, including diabetes, colon cancer, and obesity. This review provides a transdisciplinary overview of this ﬁeld, including a description of
types of resistant starches; factors in plants that affect digestion resistance; methods for starch analysis; challenges in developing food products
with resistant starches; mammalian intestinal and gut bacterial metabolism; potential effects on gut microbiota; and impacts and mechanisms for
the prevention and control of colon cancer, diabetes, and obesity. Although this has been an active area of research and considerable progress
has been made, many questions regarding how to best use digestion-resistant starches in human diets for disease prevention must be answered
before the full potential of resistant starches can be realized. Adv. Nutr. 4: 587–601, 2013.
Introduction
Growing evidence shows that many of the chronic health
conditions in developed countries could be prevented or
moderated by dietary changes. The most common starchy
foods in the United States diet, including white bread, cakes,
and noodles, consist of a large percentage of highly digestible
starch. There is concern that such rapidly digested starches
may contribute to chronic disease in people and animals
and, because of this problem, starches that are resistant to
digestive enzymes have been the focus of a growing research
emphasis. Such starches, termed resistant starches (1), have
been extensively reviewed in general (2) and reviewed from
the standpoint of their health properties (3); increasing their
content in food components (4); their health and functional
properties as a food ingredient (5); and their role in gut
health, potentially through butyrate production (6). The es-
timated daily intake of resistant starch by Americans is ~5 g
per day, much less than the minimum of 6 g of resistant
starch per meal recommended for health benefits (7).
This review summarizes the types of digestion-resistant
starches, the complexity associated with the analysis of dif-
ferent types of resistant starch, and the current status of re-
sistant starches in foods. This review addresses how, after
ingestion, normal food starch is rapidly digested and ab-
sorbed as glucose, potentiating a hyperglycemic response
and triggering insulin secretion and tissue-speciﬁc intracel-
lular uptake of glucose that can then result in hypoglycemia.
Repetition of this hyper- and hypoglycemic cycle appears to
result in insulin resistance and type 2 diabetes, thereby con-
tributing to obesity. In contrast, enzyme-resistant starches
pass through the upper digestive tract to the colon, where
they are fermented by bacteria, producing important metab-
olites, including SCFAs. These metabolites appear to have
important biological effects, including reduction of colon
cancer precursors, systemic regulation of macronutrient
metabolism, and altered secretion of hormones, which can
lead to improved physical and mental health.
Ongoing research by the authors of this review has pro-
vided important new evidence of the health beneﬁts of resis-
tant starches, showing that resistant starches with different
characteristics cause different changes to the bacteria that
1 Supported by the Plant Sciences Institute at Iowa State University and the USDA NRI/AFRI
project “Effects of Lipids on Physical Properties, Digestibility, and Nutritional Benefits of
Starchy Foods.”
2 Author disclosures: D. F. Birt, T. Boylston, S. Hendrich, J.-L. Jane, J. Hollis, L. Li, J. McClelland,
S. Moore, G. J. Phillips, M. Rowling, K. Schalinske, M. P. Scott, and E. M. Whitley, no conflicts
of interest.
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colonize the colon (i.e., microbiota) (8–11) and that resis-
tant starches can prevent or attenuate many of the parame-
ters characteristic of vitamin D deficiency associated with
type 1 diabetes (12).
Types of Resistant Starches
Resistant starch is deﬁned as a portion of starch that cannot
be digested by amylases in the small intestine and passes to
the colon to be fermented by microbiota (13). Englyst et al.
(1) proposed a classiﬁcation system based on starch diges-
tive rate. This system divides starches into rapidly digestible
starches, slowly digestible starches, and resistant starches based
on the results of in vitro digestion. There are currently 5 types
of resistant starch (Table 1). Substantial research has been
conducted on each of the 5 types of resistant starch, and
they are briefly summarized next.
Type I. Starch is synthesized in the endosperm of cereal
grains or seeds, and starch granules are surrounded by pro-
tein matrix and cell wall material. These physical structures
hinder the digestibility of starch and reduce the glycemic
response (14). When cooked as whole kernels or coarsely
ground seeds, the thick cell wall of legume seeds and the pro-
tein matrix in cereal grains prevent water penetration into the
starch in the matrix. Therefore, the starch does not have ade-
quate moisture to readily gelatinize and swell. Without proper
swelling to expose the starch molecules, the starch is not read-
ily susceptible to enzymatic hydrolysis. The cell wall material
and the protein matrix also provide a physical barrier, pre-
venting enzymes from reaching and hydrolyzing the starch.
Examples of type I resistant starch (RSI)9–containing foods
are breads made with whole or coarsely ground kernels of
grains (15) and pasta made with durum wheat by extrusion
(16). Durum wheat has a high protein content and hard tex-
ture and is used for making semolina with coarse particles.
Consequently, the postprandial glycemic response is substan-
tially lower after ingesting semolina pasta compared with
white bread. Residual starch that is not digested in the small
intestine passes into the colon as RSI.
Type II. Uncooked potato starch, green banana starch,
gingko starch, and high-amylose maize starch, which display
the B- or C-type polymorph, are highly resistant to enzy-
matic hydrolysis (17) and are examples of type II resistant
starch (RSII) However, after cooking, most of the starch,
such as that in baked potato and cooked banana, becomes
highly digestible as a result of starch gelatinization and loss
of the B- and C-type crystallites. An exception is high-amylose
starch produced by mutation of the amylose-extender (ae)
gene and the gene encoding starch branching-enzyme I,
which has substantially longer branch chains of intermediate
components and a larger proportion of amylose (18–20).
Thus, this starch displays a high gelatinization temperature,
above the boiling point of water. After boiling or cooking at
a temperature below its gelatinization temperature, this type
of starch retains its crystalline structure and remains resistant
to enzymatic hydrolysis.
Type III. Type III resistant starch (RSIII) is retrograded am-
ylose and starch (21–23). Because amylose molecules have
linear structures, they have a great tendency to form double
helices, particularly near refrigeration temperatures (4–58C)
and with adequate moisture content. Retrograded amylose
has high gelatinization temperatures, up to 1708C, and can-
not be dissociated by cooking. The gelatinization temperature
of retrograded amylose, however, decreases with shortening of
the amylose chain length. After starchy foods are stored, par-
ticularly in a refrigerator, amylose molecules and long branch
chains of amylopectin form double helices and lose their wa-
ter-binding capacity. The double helices of starch molecules
do not fit into the enzymatic binding site of amylase, thus
they cannot be hydrolyzed by this enzyme.
Type IV. Type IV resistant starch (RSIV) is a chemically
modiﬁed starch, formed either by cross-linking (24,25) or
by adding chemical derivatives (26). Starch with a high level
of cross-linking loses the ability to swell during cooking.
Consequently, the highly cross-linked starch remains in a
granular form after cooking, with little enzymatic suscepti-
bility, and cannot be hydrolyzed by amylases or fermented
by microbes. Adding a chemical derivative to starch, such
as octenyl succinic groups (27) or acyl groups (28), changes
the structure of the starch and partially restricts the enzy-
matic hydrolysis of the starch molecule, resulting in resistant
starch. A region of the starch without the derivative can be
hydrolyzed by bacteria amylases and fermented to produce
short-chain fatty acids.
Type V. When starch interacts with lipids, amylose and long
branch chains of amylopectin form single-helical complexes
with fatty acids and fatty alcohols (21,29). When the linear
starch chain is in a helical-complex structure with the
TABLE 1 Types of resistant starches1
Designation Description Example Reference
RSI Physically inaccessible starch Coarsely ground or whole-kernel grains (1)
RSII Granular starch with the
B- or C-polymorph
High-amylose maize starch,
raw potato, raw banana starch
(1)
RSIII Retrograded starch Cooked and cooled starchy foods (24)
RSIV Chemically modiﬁed starches Cross-linked starch and octenyl succinate starch (25)
RSV Amylose-lipid complex Stearic acid-complexed high-amylose starch (31)
1 RSI, type I resistant starch; (RS); RSII, type II resistant starch; RSIII, type III resistant starch; RSIV, type IV resistant starch; RSV; type V resistant starch.
9 Abbreviations used: 25D3, 25-hydroxycholecalciferol; DBP, vitamin D–binding protein; GI,
gastrointestinal; rRNA, ribosomal RNA; RSI, type I resistant starch; RSII, type II resistant starch;
RSIII, type III resistant starch; RSIV, type IV resistant starch; RSV; type V resistant starch.
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complexed fatty acid in the cavity of the helix, starch
binding and cleavage by amylase are prevented. In addi-
tion, the amylose-lipid complex also entangles amylopec-
tin molecules, restricting the swelling of starch granules
and enzyme hydrolysis (30,31). Because the amylose-lipid
complex formation is an instant reaction and the complex
can reform after cooking, type V resistant starch (RSV) is
considered thermally stable.
It is important to recognize that starch digestibility is
inﬂuenced by nonstarch components in the digest, the struc-
ture of the starch, and starch processing before digestion.
The digestibility of a given starch sample is never due to a
single factor as classiﬁcation systems suggest; rather, the ex-
trinsic factor with the greatest inﬂuence on digestibility is gen-
erally used to classify the starch.
The botanical role of starch is to provide plants with a sta-
ble reserve of glucose for metabolism. The digestibility of
starch is an important parameter in meeting this role. The
glucose reserves must be stored in a structure that is readily
available to the plant, yet able to survive for long periods of
time in storage organs such as seeds or tubers. The structure
of starch is complex and varies widely; however, the single
structural aspect with the greatest inﬂuence on digestibility
is the degree and type of crystallinity within the granule. Starch
with long, linear chains has a greater tendency to form crystal-
line structures than starch with short, highly branched chains.
Because the amylose component of starch is less branched than
amylopectin, high-amylose starch tends be more resistant to
digestion than low-amylose starch.
Sources of Variation in Botanical
Resistant Starch
Environment. The ﬁeld production environment has an
impact on starch thermal properties (32) and starch digest-
ibility (33). This effect may be a consequence of environ-
mental conditions such as temperature altering the activity
of starch biosynthetic enzymes (34). Environmental varia-
tion in resistant starch content is difﬁcult to predict and con-
trol; therefore, it has not been used as a tool for increasing
resistant starch levels.
Natural genetic variation. Starch structure varies with bo-
tanical source. Additional genetic variation occurs within
botanical sources because of allelic variation in starch bio-
synthesis genes. In commercial maize varieties, for example,
there is little variation in resistant starch levels, but exotic
germplasm contains substantial variation in resistant starch
content (33,35).
Mutations. In maize the ae locus encodes starch branching-
enzyme 2b (36). Mutations at this locus result in starch with
higher apparent amylose content (37). Campbell et al. (38)
identified exotic germplasm that in combination with ae
produces starch that is more resistant to digestion than nor-
mal ae germplasm. Genetic studies suggest that the modifier
of ae encodes starch branching-enzyme I (39). Taken to-
gether, these studies suggest that the modification of starch
branching enzymes is an effective approach to altering resis-
tant starch content. In barley, the sex6 locus encodes starch
synthase IIa and a mutation at this locus has 20% of normal
amylopectin content (40). In a study of human participants,
diets containing this barley improved several measures of
gut health compared with diets based on refined starch (41).
Biotechnology. Understanding the molecular mechanisms
controlling starch structure as it relates to digestibility has al-
lowed genetic engineering approaches to production of starch
with increased resistance to digestion. Several examples
show that suppression of starch branching-enzyme genes
results in increased amylose content in many species (42–
46). The ultimate use of this approach would be to elim-
inate all starch branching-enzyme activity. Toward this
goal, all 3 starch branching enzymes in barley were sup-
pressed using RNA interference, resulting in starch with
100% amylose that was highly resistant to digestion (47).
Methods of Starch Analysis
Dietary ﬁber is deﬁned by the American Association of Ce-
real Chemists (48) as “the edible part of plant foods or anal-
ogous carbohydrates that are resistant to digestion and
absorption in the human small intestine with complete or
partial fermentation in the small intestine." Resistant starch
is similarly functionally defined as “the starch fraction that
escapes digestion in the small intestine of healthy humans.”
Although in vivo analysis of starch digestibility in humans
may be considered ideal, in vitro analytical methods for re-
sistant starch contents of foods deriving from dietary fiber
analysis methods have been introduced and standardized.
Analysis of dietary fiber/ and resistant starch content in
foods is based on hydrolysis of available carbohydrate in
a sample, which may be accompanied by proteolysis to re-
move the protein surrounding starch and make the starch
susceptible to amylase hydrolysis. Common analytical methods
for dietary fiber content of foods include AOAC Codex
methods 991.43 (Total, Soluble and Insoluble Dietary Fi-
ber in Foods, 1994), 2001.03 (Dietary Fiber Containing
Supplemented Resistant Maltodextrin, 2004), 2009.01 (To-
tal Dietary Fiber in Foods, 2009), and 2011.25 (Insoluble, Sol-
uble and Total Dietary Fiber in Foods, 2011) (49) and the
Englyst method for dietary fiber analysis (50). Methods specif-
ically designed for determination of resistant starch content of
foods include AOAC method 2002.02 (Resistant Starch in
Starch and Plant Materials, 2002) and the Englyst method
for resistant starch analysis (1,49).
A brief summary of selected methods is presented here.
AOAC method 991.43 is used for food labeling in the United
States and European Union and measures total dietary ﬁber
as the ﬁltrate residue of a food sample after digestion with a
thermostable a-amylase from Bacillus licheniformis. This
method is rapid but is appropriate for determination of
thermostable resistant starch only, because some types of resis-
tant starch, such as raw potato starch granules (RSII), may be
destroyed during sample processing. AOACmethod 2002.02 is
a glucogenic method intended for use with raw starch samples
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and gives a direct measure of resistant starch in the intact
starch granule. Samples are hydrolyzed for 16 h using purified
porcine pancreatic a-amylase and amyloglucosidase from As-
pergillus niger. The residue collected after digestion is dried
and dispersed in potassium hydroxide solution and digested
using amyloglucosidase to give the resistant starch fraction.
Total starch content of the sample is taken as the sum of di-
gestible starch and resistant starch fractions. However, use of
purified porcine pancreatic a-amylase and the prolonged
16-h digestion period may not accurately mimic conditions of
human digestion. In addition, the procedure is lengthy and
has numerous opportunities for human error during decant-
ing of supernatants, rendering it impractical for rapid analysis
of samples containing resistant starch. The Englyst method
for resistant starch analysis (1) is intended to mimic the pro-
cess of human digestion as accurately as can be achieved in
vitro. This method uses an aqueous extract of crude porcine
pancreatin mixed with amyloglucosidase for hydrolysis of
starch up to 2 h. Samples generally are used as is for whole
foods or are boiled for raw foods before hydrolysis. Aliquots
are withdrawn after 20 and 120 min for determination of rap-
idly digestible starch and slowly digestible starch fractions, re-
spectively; resistant starch is taken as the remaining undigested
starch out of the total starch content of the sample. Some var-
iations of this method use predigestion with trypsin, HCl, or
both for better simulation of physiological digestion.
Because dietary ﬁber and resistant starch, by deﬁnition,
survive transit in the small intestine, direct measurement
of starch digestibility in isolated starches and whole foods
in patients with an ileostomy who are free of active disease
may be considered a true measure of resistant starch and di-
etary ﬁber content in foods. Physiological measurements used
as an indirect measure of starch digestibility in vivo include
postprandial serum glycemia, breath 13CO2 measurements
(51), and 2-h postprandial thermogenesis (52).
Diets supplemented with native raw potato and banana
starches, representing RSII, administered to patients with
an ileostomy have been investigated. Faisant and others (53)
investigated digestibility of green banana starch in human
ileostomates and found that a fraction composed mainly of
intact granular starch and resistant oligosaccharides compris-
ing 83.7% of the original starch weight reached the ileal termi-
nus. This value was higher than resistant starch content in
banana starch determined through in vitro analyses using a
modiﬁed Englyst method (about 70% resistant starch). This
difference was attributed to a combination of factors, includ-
ing potential differences in banana ripeness, potential failure
of the in vitro analyses to account for resistant oligosaccha-
rides, and kinetic motion of the stomach and small intestine
that is not easily replicated by in vitro methods. Cooked po-
tatoes administered to patients with an ileostomy showed
only 0.82% resistant starch in freshly cooked potatoes,
whereas potatoes that had been allowed to cool showed
1.60% resistant starch when analyzed using an Englyst
method procedure with an acid hydrolysis step (54). Re-
sistant starch contents of these 2 different meals in ileal ef-
ﬂuent were 0.54% and 1.48%, respectively, showing good
agreement with the in vitro method results. The differ-
ences between freshly cooked and cooled potato meals were
attributed to retrogradation of amylose and long amylopectin
chains characteristic of potato starches.
Vonk and colleagues (51) used breath 13CO2 measure-
ments as an indicator of gut fermentation for up to 6 h post-
prandium to compare in vivo digestibility of normal corn
starch, Hylon VII (high-amylose corn starch; Ingredion),
and Novelose 330 (a commercial RSIII prepared from retro-
graded high-amylose corn starch; Ingredion). Breath 13CO2
measurements were in good agreement with general trends
observed in starch contents of ileal effluents of individuals
fed whole diets containing similar amounts of normal and
high-amylose corn starches (55,56).
Animal models used to examine digestibility of resistant
starches include rats (57), pigs (58,59), and rabbits (60). Di-
gestibility of uncooked starches in animal models and di-
gestibility in humans must be compared with care because
of differing physiologies and, less importantly, differential
raw starch–degrading activity of animal peptic amylases
compared with those of humans. For example, porcine pan-
creatic a-amylase is commonly used as a surrogate for hu-
man pancreatic a-amylase because of its similarity to the
human enzyme (61,62). Although the rat enzyme shares
83% sequence homology with human pancreatic a-amylase
(63), it has been shown to have higher initial starch-degrading
activity than porcine pancreatic a-amylase on starches of raw,
normal maize; green banana; and potato (64). Rather than
measuring digestibility of starch content per se, animal models
generally have been used to determine effects of resistant
starch intake on existing health problems in humans, such
as diabetes (65), obesity (66), and cancers of the bowel
(67). Because animals must generally be killed to determine
physiological effects of resistant starch, a nondestructive
means for determining starch digestibility in animal models
is desirable. Recently, Anderson et al. (68) described an em-
pirical method to determine starch in rat cecal contents
using Fourier transform infrared photoacoustic spectros-
copy through partial least squares calibration. Reference
starch content values for calibrating the partial least squares
model were determined using the Megazyme total starch
kit method. The model correlated cecal content spectra
with starch content with a cross-validation correlation
coefficient (R2) of 0.997. Empirical methods such as Fou-
rier transform infrared photoacoustic spectroscopy may
be an inexpensive, rapid method for determining resistant
starch contents in feces in the context of animal studies us-
ing similar diets.
Challenges in Food Product Development
The current intake of resistant starch by Americans is lower
than recommended for providing health beneﬁts, emphasiz-
ing the need for Americans to increase the resistant starch
content of their diets (7). Foods such as potatoes, rice, pasta,
breakfast cereals, and bread are low in resistant starch (<2.5%,
dry matter basis). Cooked legumes, peas, and cooked and
cooled starchy foods are high in resistant starch (5.0–15%,
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dry matter basis) (69). Most foods in a typical Western diet
contain highly digestible starches and have a high glycemic in-
dex. Table 2 compares the resistant starch content and glyce-
mic index for several starch-based foods (7,70). Because of the
health benefits related to foods with increased resistant starch
and decreased glycemic index, there is a growing interest in de-
veloping foods with increased resistant starch contents (2,7).
The structural characteristics of resistant and normal
starches are different and relevant to the development of resis-
tant starch products (71). The characteristics of the different
types of resistant starch reﬂect the effect of processing, starch
granule characteristics, and gelatinization on the starch struc-
ture. Heating starch in the presence of adequate water contrib-
utes to starch gelatinization and an increase in digestibility.
With cooling, starches with high amylose contents retrograde
and form crystalline regions not accessible to enzymatic hy-
drolysis (72). However, swelling and gelatinization of high-
amylose starches are reduced compared with normal starches
as a result of the higher degree of crystallinity (71).
Because the different types of resistant starch differ in
their composition and structure, the effects of processing
on each type of resistant starch need to be considered indi-
vidually. With RSI, digestive enzymes are unable to hydro-
lyze the starch because of an inability to penetrate the cell
wall materials. Therefore, grinding or homogenization of
the grains can break down the cell structures and decrease
the resistant starch content. RSII is found in raw starchy
foods, and the resistant starch content would be expected to
decrease during processing that results in starch gelatiniza-
tion. On the other hand, RSIII is formed when starches gelat-
inize and recrystallize, thus resistant starch contents could
increase when those foods received further heat treatment (7).
Apart from intrinsic properties of starch affecting the for-
mation of resistant starch (e.g., crystallinity, the ratio of am-
ylose to amylopectin, granular structure), processing factors
affect resistant starch content and formation in processed
food. Baking, pasta production, extrusion cooking, auto-
claving, and other processes are known to affect both starch
gelatinization and retrogradation and inﬂuence the yield of
resistant starch in ﬁnished food (2). Some studies have re-
ported on the inﬂuence of extrusion on the resistant starch
content of corn ﬂakes and puff breakfast cereals and snacks.
For example, the formation of RSIII (mainly retrograded
amylose) in hull-less barley ﬂours was generally inﬂuenced,
but not greatly, by extrusion cooking at different tempera-
tures, moisture contents, and screw speeds (73). Huth et al.
(69) reported that extrusion conditions optimizing starch ge-
latinization, depolymerization, retrogradation, and recrystalli-
zation contribute to higher contents of resistant starch in
extruded barley. Using a single-screw extruder, both temper-
ature and moisture content were optimized to maximize
starch gelatinization, with feed moisture at 20% and a
mass temperature of 1508C resulting in the highest resis-
tant starch content. During extrusion, the shear stress of
the screw results in depolymerization of starch, which
further contributes to resistant starch formation. As the ex-
truded material leaves the extruder, resistant starch formation
continues through retrogradation and recrystallization of
the starch (69).
Use of resistant starch in baked products is limited be-
cause of adverse quality effects of resistant starch on texture,
softness, gas cell size, and gluten network formation (74–
76). Studies have been reported on the natural formation
of RSIII and its use as an ingredient in food products
(77,78). Addition of RSIII resulted in decreased pliability,
rollability, and cohesiveness in flour tortillas. High concen-
trations of RSIII led to reduced structural integrity and
therefore decreased quality of the product (74,79). The ad-
dition of 5–20% resistant starch to muffins contributed to
overall decreased quality, with chewiness, cohesiveness,
and volume affected (80,81). Resistant starch type has had
an impact on acceptability and textural quality when incor-
porated into muffins. Although the incorporation of either
RSII or RSIII decreased muffin quality, the quality of muffins
with RSII was more acceptable than muffins with RSIII (78).
The substitution of 20% RSV with added vital wheat glu-
ten for wheat ﬂour resulted in bread with 11.5% resistant
starch that was comparable to the control. Substitutions
up to 50% resulted in increased resistance to gelatinization
and decreased gluten network formation, contributing to
decreased loaf volume, increased density, and decreased
consumer acceptability. The addition of dough conditioners,
ﬂavor maskers, and colorants improved the sensory attributes
of the breads (MO Reed, TD Boylston, and J Jane, unpub-
lished results).
TABLE 2 Comparison of resistant starch content and glycemic
index for commonly consumed starchy foods1
Resistant starch
Glycemic
index
g/100 g
Grain and cereal products
Buckwheat 1.8 51
Bread (white) 1.2 69
Bread (whole meal) 1.0 72
Millet 1.7 71
Rice (brown) 1.7 66
Rice (white) 1.2 72
Spaghetti (whole meal) 1.4 42
Spaghetti (white) 1.1 50
Breakfast cereals
All-Bran (Kellogg’s) 0.7 51
Cornflakes 3.2 80
Muesli 3.3 66
Porridge oats 0.2 49
Shredded wheat 1.2 67
Wheatabix 0.1 75
Vegetables
Broad beans 1.2 79
Potatoes (white) 1.3 80
Potatoes (sweet) 0.7 48
Sweetcorn 0.3 59
Yam 1.5 1.5
Legumes
Beans (baked) 1.2 40
Beans (kidney) 2.0 29
Peas (chick) 2.6 36
Lentils 3.4 29
1 Resistant starch data from (7); glycemic index data from (70).
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Further research is necessary to understand the effects
of processing on the content of resistant starch in a range
of food products. Depending on the type of resistant starch
in these food products, the use of various food additives
may be necessary to produce foods with acceptable quality
attributes. The development of food products with increased
resistant starch contents and acceptable quality attributes is
imperative to provide foods with increased health beneﬁts to
consumers.
Gut Bacterial Metabolism of
Digestion-Resistant Starch
Bacteria in the lower intestines of humans may be exposed
to as much as 20 g of resistant starch per day (82). The fer-
mentation products of resistant starch by gut bacteria include
gases (methane, hydrogen, carbon dioxide) and SCFAs (ace-
tate, propionate, butyrate, and valerate). Much lesser amounts
of organic acids (lactate, succinate, and formate), branched
SCFAs (isobutyrate and isovalerate), and alcohols (methanol
and ethanol) are also produced. Starch degradation is a coop-
erative process in the lower gut, generalized as 1) degradation
of starch polymers into glucose; 2) glycolysis with SCFA or
other organic acids as end products; and 3) methane produc-
tion by methanogenic Archeae spp. from formate, hydrogen
gas, and carbon dioxide products of bacterial metabolism of
resistant starch. These processes involve several bacterial
groups, as described next.
Amylolytic gut bacteria. Gut bacterial amylase-mediated
starch breakdown includes a-amylase for a-1,4 linkage,
type I pullulanase for a-1,6 linkage, and amylopullulanases
for both a-1,4 and a-1,6 linkages (83). Three major phyla,
Firmicutes, Bacteroidetes, and Actinobacterium, which ac-
count for 95% of total mammalian gut bacteria, are involved
in starch fermentation. Macfarlane et al. (84) used peptone-
yeast agar plates to screen soluble starch-hydrolyzing strains,
noted by clearing zones around colonies. From 120 amylo-
lytic colonies randomly selected from fecal samples of 6 hu-
man participants, 58% were identified as Bifidobacterium
spp., with lactate and acetate as major products. About
18% of starch-hydrolyzing fecal isolates were identified as
Bacteroides spp., with acetate and propionate as major pro-
ducts, and another 10% were identified as Fusobacterium
and Butyrivibrio, with butyrate as the major product. Wang
et al. (85) screened 38 human colonic bacteria strains with
this technique (84) but used autoclaved starch granules to
mimic food preparation. Although Bifidobacterium spp.; Bac-
teroides spp.; Fusobacterium spp.; and strains from Eubacte-
rium, Clostridium, Streptococcus, and Propionibacterium all
had amylase activity to utilize high-amylopectin and soluble
starch, only Bifidobacterium spp. and Clostridium butyricum
could efficiently utilize high-amylose starch granules. These
species would be of particular importance to gut bacterial fer-
mentation of high-amylose starch (i.e., RSII).
Bacterial binding to starch granules is probably impor-
tant for bacterial starch fermentation in the lower intestine.
Two structures have been identiﬁed for starch binding: the
cellulosome in Ruminococcus flavefaciens for insoluble sub-
strates (86) and outer membrane protein complex in Bacte-
roides thetaiotaomicron for soluble substrates, including
starch-utilization-structure (sus) gene clusters that bind to
and hydrolyze starch (87). It is unknown whether other Ru-
minococci have cellulosomes, but Ruminococcus bromii, en-
riched by resistant starch in vivo and in vitro (88), is closely
related to R. flavefaciens.
The starch-binding ability in other Gram-positive bacteria
might be mediated by cell-associated a-amylase. Cell-associated
amylases were identified in Butyrivibrio fibrisolvens, Roseburia
inulinviorans, and Roseburia intestinalis, all butyrate-producing
bacteria (11). Cosedimentation was used to examine the
affinity of 19 Bifidobacterium strains with high-amylose
starch in vitro (12). Two amylolytic strains, Bifidobacterium
pseudolongum (American Type Culture Collection 25526)
and Bifidobacterium adolescentis (Technical Research Centre
of Finland E-001561), had the highest affinity and specificity
for a-1,4–linked glucose sugars. Starch binding could be in-
hibited by pancreatin and low pH (<3), indicating that cell
surface proteins were involved in starch attachment. Strong
attachment by Bifidobacterium spp. to starch granules might
partly explain the enrichment of these species by dietary re-
sistant starch.
Butyrogenic bacteria. Barcenilla et al. (89) described isola-
tion of butyrogenic bacteria in 2 fecal samples each from
1 infant, 1 adult omnivore, and 1 adult vegetarian. Bacteria
from fresh fecal suspension was grown on M2 medium sup-
plemented with glucose, soluble starch, and cellobiose, and
butyrate production >2 mM in this medium was used as the
criterion for designating butyrate-producing bacteria (23%
of the >300 isolates tested showed this ability). Based on
full-length 16S ribosomal RNA (rRNA) sequences, 80% of
butyrate-producing isolates fell within the XIVa bacterial
cluster, with the most abundant group (42%) related to
Eubacterium rectale, Eubacterium ramulus, and Roseburia
cecicola. Many members from cluster XIVa (or Roseburia/
coccoides/E. rectale group) and cluster IV (Clostridium leptum
group) (families Lachnospiraceae and Ruminococcaceae, re-
spectively) are frequently detected in human fecal micro-
biota, as summarized by Pryde et al. (90).
Two mechanisms for butyrate production involving
butyrate kinase and butyryl-CoA:acetate-CoA transferase
have been inferred (91). After hydrolysis of glucose through
the Embden-Meyerhof-Parnas pathway, pyruvate is the
major precursor of butyrate, with further conversion into
acetyl-CoA, lactate, and succinate by gut microorganisms.
Acetyl-CoA can be used for butyrate synthesis by butyrate
kinase (92) or converted into acetate. Acetate can also be
utilized by butyryl-CoA:acetate-CoA transferase as a CoA
acceptor in bacteria, such as Roseburia intestinalis (93).
A third route has been implicated recently by Belenguer
et al. (94) who cocultured lactate-producing bacteria B. adoles-
centis with starch-utilizing bacteria Eubacterium hallii and
Anaerostipes caccae in yeast extract–casitone–fatty acid me-
dium supplemented with soluble potato starch. From tracing
592 Birt et al.
 at IO
W
A STATE UNIVERSITY on February 17, 2016
advances.nutrition.org
D
ow
nloaded from
 
the (1-13C)-labeled acetate or (U-13C)-labeled lactate, butyrate
was converted directly from lactic acid without involvement of
exogenous acetate.
The distribution of genes encoding butyrate kinase (buk)
and butyryl-CoA:acetate-CoA transferase (ptb) in gut bacte-
ria were largely unknown until the study of Louis et al. (95).
They obtained 38 butyrate-producing isolates from 4 partic-
ipants and identified the genes using PCR. They found that
only 4 out of 38 butyrate-producing strains contained buty-
rate kinase genes, whereas the butyryl-CoA:acetate-CoA
transferase gene was detected in all isolated bacteria, consis-
tent with another report that 50% of butyrate-producing
bacterial isolates showed significant correlation between bu-
tyrate production and acetate disappearance (r2 = 0.6) (89).
Sequences (1718) were obtained with degenerate primers to
amplify butyryl-CoA:acetate-CoA transferase genes from fecal
samples from 10 healthy humans(99). Thirty-two butyryl-
CoA:acetate-CoA transferase–related sequences (cutoff >
98% similarity) were found, 4 from E. rectale, Roseburia fae-
cis, E. hallii, and an unnamed cultured species SS2/1 that was
highly abundant in the human gut.
In addition to the varying abundance of bacterial species
or key functional genes in the gut, butyrate-producing ability
may vary among bacterial species. Louis et al. (95) showed var-
ied activity of butyrate kinase and butyryl-CoA:acetate-CoA
transferase among strains and species of butyrate-producing
isolates. Metagenomic analysis revealed butyrate kinase–
related genes as one of the most enriched Clusters of Orthol-
ogous Groups in fecal bacteria from 2 human participants,
whereas butyryl-CoA:acetate-CoA transferase was not en-
riched (97). Thus, investigators using differing approaches
have implicated either bacterial butyrate kinase or butyryl-
CoA:acetate-CoA transferase to predominate in butyrate-
forming gut bacterial pathways, based on a very limited number
of fecal samples. Other genes regulating butyrate production
have not been identified. In addition, although some Bacteroides
spp. and Clostridium spp. are known to produce propio-
nate, its production pathway and the regulation of its pro-
duction in bacteria are unknown. Detailed functional
analysis of bacterial SCFA–producing activity is antici-
pated with transcriptomics.
Methanogenic Archaea. The production of methane,
which can be considered as the ﬁnal end product consuming
hydrogen and carbon dioxide, is another fermentation out-
come. The distribution of methanogenic Archaea in human
fecal bacterial populations is an example of interindividual
variability. The proportion of methane producers in the
population varied from 24% in Asians to 48% in Caucasians
by measuring breath hydrogen after lactulose intake (98).
Methanogenic Archaea might affect the fermentation ca-
pacity of individuals. The abundance of methanogenic Ar-
chaea was negatively related to fecal butyrate concentration
(r = 20.729, P < 0.05, n = 8) but not to other SCFAs,
with PCR–denaturing gradient gel electrophoresis analysis
using methanogen-specific primers coupled with real-time
PCR (99). This study confirmed results from human and
rat in vitro fecal fermentation, showing that individuals whose
feces produced greater amounts of methane also produced
lesser amounts of butyrate (100). Although genome sequences
of 2 methanogens are available, their physiological and health
importance is still unknown. With the great range of possible
competition and cross-feeding among gut bacterial species,
further studies are needed to identify the role that methano-
genic Archaea play in resistant starch fermentation.
In summary, the utilization of resistant starch is cooper-
ative and redundant in the gut. The identiﬁcation of bacteria
or bacterial functions related to resistant starch fermenta-
tion is important for predicting health outcomes of ingest-
ing resistant starch. Progress has been made in identifying
the gut bacteria related to resistant starch fermentation and
in characterizing the metabolic mechanisms of bacterial resis-
tant starch fermentation, which are crucial for understanding
mechanisms and conditions under which digestion-resistant
starches may help to prevent diseases.
Resistant Starch and Gut Microbiota
It is often recognized that the mammalian gastrointestinal
(GI) tract is home to more bacterial cells than comprise
the entire host. It is also well established that GI microbiota
make important contributions to the health of the host, in-
cluding immune system development, nutritional acquisition,
and protection against infection (101). In recent years, new ev-
idence has greatly increased our understanding of microbiota
impacts on host health. For example, an altered microbiota
(dysbiosis) has been associated with human diseases, such as
diabetes, obesity, inﬂammatory bowel diseases, and colorectal
cancer (101). GI microbiota have recently been shown to con-
tribute to neurological diseases and inﬂuence host behavior
(102). These insights have led to a heightened interest in the
role of the diet in modulation of GI microbiota as a means
to improve host health (91,103,104) and a new awareness of
how diet can contribute to disease (101,105).
It has long been known that diet inﬂuences the microbial
communities of the GI tract. Diet-induced changes in these
microbiota can have beneﬁcial effects on the health of the
host through the breakdown of dietary ﬁbers and production
of SCFAs, which are an important source of energy for the
host and perform important immune modulatory roles
(106,107). Although studies to understand how different clas-
ses of resistant starch affect microbiota are limited, it is clear
that high-ﬁber diets greatly affect the composition of mamma-
lian microbiota (9,10). Microbiota also reduce harmful
metabolites, including bile acids, phenol, and ammonia,
and inﬂuence dietary fat metabolism, which inﬂuences obe-
sity. Changes in microbiota can occur rapidly after dietary
changes. These effects can be both direct and indirect, that
is, bacteria that can digest resistant starch generate energy,
which provides them with a growth advantage in the gut (9).
Changes in community composition can also occur from de-
creased pH, resulting from accumulation of SCFAs (108,109).
Other by-products of resistant starch fermentation can be
used by other classes of bacteria to enhance their abundance
through metabolic cross-feeding (110).
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Studies using rodent models revealed correlations between
resistant starch diets and colonic pH, SCFA composition,
and enzymatic activity associated with bacterial degradative
pathways, and the abundance of several bacterial taxa (91).
Studies have also been conducted on humans fed diets
rich in resistant starches, which likewise revealed changes
to the function or abundance of major groups of bacteria
(111,112).
Because the vast majority of GI bacteria cannot presently
be cultured in vitro, our understanding of the composition
of GI microbiota has recently accelerated with the applica-
tion of culture-independent bacterial community analysis
(metagenomics) and next-generation sequencing technolo-
gies (113). Techniques associated with deep DNA sequenc-
ing include proﬁling the main taxa comprising complex
bacterial communities by 16S rRNA gene sequencing or
whole-genome sequencing that can also reveal functional
changes within the community. DNA sequencing platforms
associated with these approaches include pyrosequencing
technology of Roche/454 systems and the more recent appli-
cation of shorter-read Illumina sequencing (113). These sys-
tems have been used as part of large, comprehensive studies
in both the United States (Human Microbiome Project) and
Europe and China (Metagenomics of the Human Intestinal
Tract Study) to characterize the microbiota from various lo-
cations, including the GI tract, from healthy adults (114–
116). The Human Microbiome Project included both 16S
rRNA gene phylotyping and whole-genome shotgun se-
quencing from multiple body sites over time (114), whereas
the Metagenomics of the Human Intestinal Tract Study used
shotgun metagenomic analysis of human fecal samples. The
latter study revealed 3 distinct “enterotypes” characterized
by their relative abundance of Bacteroides, Prevotella, and
Ruminococcus genera in human populations (115). Although
studies on this classification system are ongoing (117), diets
that differ in fiber content appear to influence the composi-
tion of many of the major taxonomic units that produce
SCFAs and offer beneficial effects to the host (118).
Martínez et al. (8) used pyrosequencing to characterize
the impact of resistant starches on the composition of
fecal microbiota in humans. Study participants consumed
resistant starch representing either RSII (granular form of
high-amylose corn starch) or RSIV, (chemically modified by
phosphate cross-linking), which were compared with con-
trol starch in the form of crackers. Both forms of resistant
starch increased representatives of the Actinobacteria and
Bacteroidetes phyla and decreased Firmicutes. The 2 forms
of resistant starch differed in their ability to change species.
RSII increased the abundance of R. bromii and E. rectale,
which was consistent with prior results from in vitro studies
of starch fermentation in the large intestine (119,120). In
contrast, RSIV was associated with increased B. adolescentis
and Parabacteroides distasonis (8). Why the 2 different resis-
tant starches change the composition of the microbiota
remains unclear, because multiple genera are capable of
degrading the starches (86,121). It was suggested that the
differential ability for individual bacterial species to degrade
the starches may represent differences in substrate binding
(8).
Individual study participants also appeared to have widely
different responses to dietary starch (8,9). For example, in
the Martínez et al. study (8) none of the taxa showed the
same response in all 10 individuals, likely reflecting the
known microbial variation throughout human populations
(122,123). Strain differences in the ability to degrade the re-
sistant starches (124) and host factor differences that distin-
guish the human participants also likely contribute to these
changes. This finding is consistent with the observations
that the products of GI fermentation (i.e., SCFAs) can vary
greatly among individuals and their levels also correlate
with diet (125,126).
Although deep-sequencing studies of the impact of resis-
tant starches on colonic microbiota have only recently been
initiated, they should help identify the mechanisms by
which speciﬁc bacterial taxa interact with the different forms
of starch. The interindividual variation in response to die-
tary resistant starch will also be an important area of inves-
tigation for the therapeutic and preventive use of resistant
starch to improve human health (8).
Another topic of intense interest is the use of prebiotics to
alter colonic microbiota to beneﬁt the health of the host
(127). Although typically associated with oligosaccharides,
prebiotics can represent a variety of nondigestible carbohy-
drates, including resistant starch (128), that impart health
beneﬁts to the host through modulation of GI bacteria
(129). Because of the interactions between GI microbiota
and hosts, prebiotics, including resistant starches, have the
potential to correct or prevent a variety of human diseases,
including obesity, diabetes, inﬂammatory bowel diseases,
and cancer (130,131).
Potential Impacts and Mechanisms of Action of
Resistant Starch in Prevention of Colon Cancer
Consumption of diets with abundant ﬁber has long been be-
lieved to protect against colorectal cancer (132). More re-
cently, resistant starch has received attention for potential
prevention of colon cancer and inﬂammatory bowel diseases
(104). Although studies of resistant starches and human co-
lonic health have been limited, abstracts describing 2 recent
human interventions were found. In 1, a 4-wk intervention
with red meat (300 g/d) increased O6-methyl-29-deoxygua-
nosine adducts and genes from the microRNA-17–92 cluster
(overexpressed in colorectal cancer) in the colons of humans.
However, these features were not elevated with a 4-wk inter-
vention that included red meat plus butyrylated resistant
starch (40 g/d) (133). These results suggested that resistant
starch may protect the human colon against potentially dam-
aging aspects of dietary red meat. In the second human trial,
with hereditary nonpolyposis colorectal cancer gene carriers
(patients with Lynch syndrome) at high risk for developing co-
lon polyps and cancer, a diet containing 30 g/d maize starch
(Novelose, Ingredion) was compared with placebo diet for
29 mo. No impact on polyp or colon cancer development
was observed at a 4-y follow-up (134).
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In contrast to the limited number of human interven-
tions evaluating dietary resistant starch, several studies
have been done on the impacts of resistant starch and colon
cancer prevention in laboratory animals. Le Leu et al.
(67,135,136) conducted extensive studies in rats treated
with the colon carcinogen azoxymethane and/or fed diets
high in protein to damage the colonic epithelium. Feeding
high ﬁber or resistant starches increased fecal bulk, fecal
pH, butyrate concentration, and epithelial apoptosis, and
it decreased cell proliferation markers and colon carcino-
genesis. When animals were fed high levels of protein, the
addition of high-amylose resistant starch reduced protein
fermentation products, which paralleled reduced colorec-
tal carcinoma development. In contrast to these ﬁndings,
studies with potato ﬁber or potato resistant starch in rats
fed control protein or high-protein diets revealed no im-
pact of dietary resistant starches on DNA damage in the
colon (137). It is not clear whether the contrasting results
are due to differences in experimental details, including
the starches fed, or other factors. DNA damage was studied
in rats fed diets with casein or soy protein and resistant
starch (48% high-amylose maize starch), with attenuated
DNA damage observed in rats fed high-protein diets and
resistant starch (138). Butyrylated high-amylose corn starch
was shown to be somewhat more effective than high-amylose
corn starch in the inhibition of colon cancers in rats (139). Re-
sults from Zhao et al. (140), using a novel high-amylose starch
complexed with steric acid (RSV) revealed a stunning reduc-
tion in mucin-depleted foci; however, subsequent studies
found that mucin-depleted foci may not be a reliable marker
for subsequent colon cancer (B Nelson, Y Zhao, N Cray,
E Whitley, and DF Birt, unpublished results).
Numerous hypotheses have been proposed for the poten-
tial mechanism by which colon carcinogenesis may be altered
by resistant starch. The most common hypotheses focus on
alteration of the water-holding capacity of the fecal stream,
modiﬁcation of the microbiota, and increasing SCFA pro-
duction. Although the SCFA hypothesis seems to have the
most enthusiastic following, theories on the impacts of die-
tary resistant starch on the production of SCFAs and chang-
ing the microbiota are gaining momentum (141).
SCFAs (acetate, proprionate, and butyrate) are increased
in amount and concentration in many studies of resistant
starch and colon health (104,132). Butyrate, an end-product
of microbial fermentation of resistant starch and the pri-
mary energy source for colonocytes, is actively transported
into cells by a Na+-dependent cotransporter (142). This
cell membrane transporter serves as a tumor suppressor
gene and is epigenetically silenced by hypermethylation
in human aberrant crypt foci (a precancerous lesion) and co-
lorectal cancer (143). Butyrate has been of particular interest
because of the role this molecule plays in colonic epithelial
metabolism and differentiation and its influence on signaling
pathways that regulate mucosal physiology (141,144). In cell
culture, butyrate has antitumorigenic properties, including re-
ducing cell proliferation and inducing apoptosis of colorectal
tumor cell lines (141). However, it is not clear whether the
concentrations of butyrate achieved in the colon of animals
and humans fed resistant starches are optimal for the suppres-
sive effects observed in cultured cells, because the concentra-
tions of butyrate in animals fed control diets are higher than
the concentrations of butyrate needed for suppression of co-
lon proliferation (145).
Colon cancer appears to develop as the result of dysregu-
lation of molecular pathways that control epithelial prolifer-
ation, maturation, and apoptosis, with perturbations of both
genetic and epigenetic components. In regeneration of nor-
mal mucosa, stem cells deep within the crypt undergo mitosis,
with subsequent maturation and differentiation of daughter
cells to mature absorptive and secretory populations of the
colonic mucosa and eventual loss of aged or damaged cells
through apoptosis. Multistep accumulation of mutations
of genes in critical control pathways, coupled with changes
in epigenetic factors, is believed to allow survival of abnor-
mal crypt epithelial cells with the potential to undergo ma-
lignant transformation.
The molecular mechanisms by which dietary resistant
starches are believed to alter the development or progression
of colon cancer are incompletely understood. Potential mech-
anisms of action of dietary resistant starch on gene expression
and mutation, DNA methylation, histone modiﬁcation, and
remodeling of chromatin are being studied intensively. Re-
cently, animal studies identiﬁed both alterations in the micro-
biota and induction of protection against unrepaired DNA
damage by dietary high-amylose maize starch and butyrylated
high-amylose, with increased expression of genes involved in
repair of DNA (146), which, in rapidly dividing populations
of the colonic mucosa, is expected to result in fewer mutations
and reduced carcinogenesis. Butyrate has been also described
to exert an inﬂuence on cell proliferation and differentiation
through modulation of several signal transduction pathways
(147). In some colon cancer cell lines, constitutive expression
of the canonical Wnt pathway, an initiating event in most co-
lorectal cancers, is upregulated by butyrate treatment, resulting
in a strong apoptotic response (148). Butyrate has also been
shown to influence gene expression in the colon by modulat-
ing RNA splicing (149).
The potential for modiﬁcation of epigenetic mechanisms,
by their nature potentially reversible, by metabolic products of
resistant starch also holds promise for dietary prevention of
colorectal cancer. Butyrate is well known as an inhibitor of his-
tone deacetylase, an enzyme that modiﬁes wrapping of strands
of DNA around nuclear histone proteins and thereby regulates
gene transcription. Inhibitors of histone deacetylation, such as
butyrate, have the ability to modify expression of genes that
control cell cycle and apoptosis and function to suppress the
development of pre-neoplastic and neoplastic phenotypes in
vitro (150). Furthermore, butyrate exerts protective effects
against intestinal mucosal inﬂammation, a component of
inﬂammation-mediated colorectal cancer, through apo-
ptosis of T lymphocytes and inhibition of inducible nitric
oxide synthase in colonic epithelium (151).
The potential contributions to colonic homeostasis by en-
dogenous ormicrobial products of resistant starchmetabolism
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other than SCFAs are undetermined. Complex interactions
between microbiota, dietary components, colonic epithelium,
the immune system, and the nervous and endocrine systems
are being dissected, and it is likely that mechanisms integrating
these components will emerge.
Potential Impacts and Mechanisms of Action
of Resistant Starch in Prevention or Therapy
of Metabolic Diseases
Diabetes. Diabetes affects 8% of the United States popula-
tion and 23% of the population >60 y of age, mostly as
type 2 diabetes. Both type1 and type 2 diabetes are charac-
terized by hyperglycemia, subsequently resulting in systemic
tissue toxicity. Some risk factors, including increased fasting
and postprandial glucose response as well as decreased insu-
lin sensitivity and obesity, are reversible through lifestyle
modifications, which were found to be more effective than
pharmacological interventions in delaying the onset of
type 2 diabetes (152). One such lifestyle change is the re-
placement of ordinary starch in foods with resistant starch,
owing to its low glycemic index. It has been reported in hu-
man studies that consuming foods, including corn porridges
(153) and crackers (E Haugabrooks, Y-FAi, J Jane, S Hendrich,
unpublished results), with a high content of resistant
starch resulted in lower postprandial glucose concentrations
and concomitant insulin response compared with consum-
ing foods containing ordinary starch (30,154). In addition,
consuming less digestible starches may decrease glycemic re-
sponse to a subsequent meal, the “second meal effect.” Ten
healthy individuals who ate high-amylose starch at breakfast
showed decreased blood glucose response to a lunch con-
taining highly digestible carbohydrate, compared with eating
high-amylopectin starch at breakfast (155). Consequently,
replacing ordinary dietary starch with resistant starch con-
tributes to diabetes management. Increasing consumption
of resistant starch can also aid weight management, benefi-
cially influence body composition, or both in part because
food with resistant starch has lower energy concentration
and has been shown in mice to reduce body fat, an important
predictor of disease (156,157). Animal models of diabetes have
also demonstrated a positive effect of dietary resistant
starch, such as an improvement in glycemic control in the
Goto-Kakizaki rat, a nonobese model of type 2 diabetes (65).
The potential for low glycemic index carbohydrates, such
as resistant starch, to reduce diabetic complications may be
related to protection of kidney function and lead to better
maintenance of adequate nutritional status, particularly
with respect to vitamin D. Numerous epidemiological and
case-control studies have reported vitamin D insufﬁciency
in type 1 and type 2 diabetes (158–163). However, it is un-
clear whether low vitamin D exposure contributed to the
onset of diabetes or whether low vitamin D status was a con-
sequence of diabetes. The major circulating form of vitamin
D, 25-hydroxycholecalciferol (25D3), circulates bound to vi-
tamin D–binding protein (DBP) until the 25D3-DBP com-
plex is internalized through endocytosis and activated to
1,25-dihydroxycholecalciferol by the renal proximal tubule
cells or reabsorbed into the blood as 25D3 (164). In both
type 1 and type 2 diabetic rats, excretion of 25D3 and
DBP into the urine was markedly elevated as a result of pa-
thologies associated with reduced expression of megalin
and disabled-2, which partner together to facilitate the uptake
of the 25D3-DBP complex by the kidneys (12,165). However,
when cornstarch in the AIN-93G rodent diet was replaced
with high-amylose maize, that is, ~37% resistant to digestion,
urinary excretion of vitamin D metabolites and DBP was vir-
tually prevented in diabetic rats (12). Of interest was the find-
ing that feeding diabetic rats the resistant starch had only a
slight effect on attenuating fasting blood glucose concentra-
tions, yet the renal expression of megalin and disabled-2
were normal, as confirmed in a type 2 diabetes rat model
(G Koh and M Rowling, unpublished results).
Obesity and body weight management. Overconsumption
of energy is proposed to be responsible for the obesity epi-
demic, and, as a consequence, new strategies are required
to reduce energy intake (166). One potential dietary strategy
is to increase consumption of dietary ﬁber, which has been
associated with increased satiety and lower BMI (167–169).
Dietary fiber is a diverse group of carbohydrates, and large
differences exist in their physical and chemical properties.
Consequently, not all sources of fiber will have the same ef-
fect on satiety or body weight (167). Resistant starches are
proposed to provide many of the benefits of dietary fiber;
therefore, they may aid weight management, although it
has yet to be adequately demonstrated.
Accumulating evidence from rodent studies suggests
that replacing rapidly digestible starch with resistant starch
reduces body weight. Aziz et al. (170) found that a diet high
in resistant starch reduced body weight by 40% in diet-
induced obese rats. However, the diet contained 23.4% re-
sistant starch, an amount that may not be achievable in
human diets. Another study fed rats a diet containing 4%,
8%, or 16% resistant starch and found that consuming a
diet with >8% resistant starch reduced adiposity compared
with 0%, and for every 4% increase in resistant starch,
energy intake was reduced by 9.8 kJ/d (66). Long-term
studies on the effect of increasing resistant starch con-
sumption on body weight in humans are required.
Despite the lack of long-term studies, there are several
reasons to believe that consuming resistant starch could aid
weight management in humans. First, because of the lower
calorie content, replacing rapidly digestible starch with resis-
tant starch reduces the energy density of the diet (171,172).
Several studies have found that reducing the energy density
of the diet increases satiety and weight loss (173–176).
Second, incorporating resistant starch into a meal may
augment feelings of satiety. Although ﬁber intake has been
associated with increased satiety, the effect of resistant starch
on satiety is less clear. In rodent models, adding resistant
starch to the diet increased secretion of the putative satiety
hormones GLP-1 and PYY (171,172), suggesting that it
might augment satiety. The few studies that have been con-
ducted in humans have provided mixed results. Willis et al.
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(177) provided participants with low-ﬁber mufﬁns or muf-
ﬁns supplemented with resistant starch for breakfast and
found that consuming the mufﬁns containing resistant
starch promoted satiety and increased the duration of satiety.
Bodinham et al. (178) fed males 48 g of resistant starch across
2 separate meals and found no effect on subjective appetite, al-
though food intake was reduced by ~1300 kJ over 24 h. Con-
versely, a recent study that fed participants a breakfast meal
containing 25 g of resistant starch had no effect on subjective
appetite or food intake over the remainder of the day (179).
This study also found that plasma concentrations of GLP-
1 were lower after the resistant starch meal.
Third, resistant starch may inﬂuence body weight by
increasing energy expenditure or fat oxidation. It has been
proposed that replacing rapidly digestible starch with resistant
starch may promote fat mobilization as the result of a re-
duction in insulin secretion (180). However, currently, little
evidence supports this hypothesis and several studies have
failed to show that resistant starch increases energy expendi-
ture or fat oxidation (52,181,182).
Discussion
Digestion-resistant starches are categorized on the basis of
their resistance to digestive enzymes and are the subject of
investigation for inclusion in healthy foods. Environmental
and genetic factors that affect starch resistance in crops are
being identiﬁed, including using biotechnology to control
starch digestibility. Although both in vivo digestion and in
vitro digestion of starches have received considerable atten-
tion, there is a need for improved, validated in vitro methods
that reﬂect in vivo digestion under the myriad conditions
the starch may encounter in animal and human digestion.
Further, although several challenges have been identiﬁed
in attempts to incorporate resistant starch into human diets,
much work must still be done to effectively overcome the
identiﬁed barriers.
The complexity of resistant starch effects on gut micro-
biota and microbial effects on resistant starch metabolism
has been the focus of much work. With the application of
new genomic techniques to gut microbiota, the pace of pro-
gress is anticipated to accelerate. In addition, to best inter-
pret gut microbiota data, we need advances to expand the
capabilities of resistant starch analytical methods, which still
depend greatly on methods developed earlier for dietary ﬁber.
Finally, studies of resistant starch on disease processes, in-
cluding colon cancer, diabetes, and obesity, show promise,
and intriguing hypotheses have been developed. However,
there is a need for considerable research to identify the
potential effectiveness of digestion-resistant starches in
the prevention and control of human diseases and to iden-
tify mechanisms underpinning their actions. In particular,
considering the tremendous diversity of digestion-resistant
starches in plants, very few of these starches have been stud-
ied for their effects on animals or humans. Future integra-
tive research that addresses all of these fronts will help
expand the potential uses for digestion-resistant starches
in health promotion.
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